Back to all journals
journal articles
LETTER TO THE EDITOR: CONCERNS ABOUT ANAVEX\'S CLINICAL TRIAL OF BLARCAMESINE
Jesse Brodkin
J Prev Alz Dis 2025;5(12)
CITATION:
Jesse Brodkin (2025): Letter to the Editor: Concerns about Anavex's clinical trial of Blarcamesine. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2025.100137